Ace Biomed Collaborates with Aurora World Subsidiary to Target Small Mask Market

President Han Hyun-woo (left) of Ace Biomed Mask Division and CEO Park Sang-su (right) of Smile Bio held a business agreement signing ceremony at the Aurora World headquarters.

[Asia Economy Reporter Jang Hyowon] Ace Biomed, a subsidiary of Sangji Kyleum, announced on the 15th that it has signed a business agreement with Smile Bio, a subsidiary of character toy specialist Aurora World, to launch small-sized masks and enter the global market.

Ace Biomed, specialized in K-quarantine products such as COVID-19 diagnostic kits and non-contact thermometers, also possesses 35 years of mask manufacturing technology. It currently produces various types of KF-certified masks and daily masks, which are sold domestically and internationally.

Smile Bio, which signed the business agreement with Ace Biomed, is a mask distribution company established by Aurora World, a character toy specialist with 40 years of experience. Utilizing popular characters owned by Aurora World such as "Pinkfong Baby Shark," which has recorded 3.2 billion YouTube views, and "Yoohoo and Friends," currently popular on Netflix, Smile Bio sells and distributes masks. The two companies plan to actively target the global market through collaboration, including producing masks featuring popular characters.

Ace Biomed has completed the US FDA registration for its KF-grade mask products and is currently working with a local company in Los Angeles on obtaining NIOSH certification for medical professional masks. This business cooperation has secured export competitiveness from medical professional masks to small-sized children's masks.

A company official stated, "Through this business agreement with Aurora World's subsidiary, we have been able to enter the global children's mask market," adding, "We expect initial market entry to be possible by utilizing popular and verified characters in marketing."

Meanwhile, Ace Biomed is a company possessing technology for COVID-19 rapid diagnostic kits and liver disease diagnostic kits. Its COVID-19 rapid diagnostic kit recently obtained export approval from the Ministry of Food and Drug Safety and subsequently received usage approval from Mexico's equivalent agency, 'InDRE,' accelerating its entry into the global market. Recently, it completed a merger with a mask manufacturing company with 35 years of tradition, in which it holds 100% equity, and is diversifying as a COVID-19 quarantine specialist company.

This content was produced with the assistance of AI translation services.